We are live on ! Find out more
KURA icon

Kura Oncology
KURA

28 hedge funds and large institutions have $60.9M invested in Kura Oncology in 2016 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

141% more capital invested

Capital invested by funds: $25.2M → $60.9M (+$35.7M)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

12% more funds holding

Funds holding: 25 → 28 (+3)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
28
Holders Change
+3
Holders Change %
+12%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
6
Increased
8
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
+$1.7M
2
EC
EcoR1 Capital
California
+$743K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$399K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$248K
5
PPCM
Pillar Pacific Capital Management
California
+$155K

Top Sellers

Rank Fund Capital Flow
1
BC
Boxer Capital
California
-$509K
2
CCP
Clough Capital Partners
Massachusetts
-$391K
3
MA
Minerva Advisors
Pennsylvania
-$200K
4
Goldman Sachs
Goldman Sachs
New York
-$64K
5
TRCT
Tower Research Capital (TRC)
New York
-$51.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$17.6M – – –
EC
2
EcoR1 Capital
California
$16.3M +$743K +146,620 +6%
PHS
3
PFM Health Sciences
California
$12.5M +$1.7M +336,478 +20%
CCP
4
Clough Capital Partners
Massachusetts
$4.19M -$391K -77,180 -10%
BC
5
Boxer Capital
California
$3.33M -$509K -100,441 -16%
Vanguard Group
6
Vanguard Group
Pennsylvania
$2.33M +$399K +78,750 +27%
MA
7
Minerva Advisors
Pennsylvania
$2.01M -$200K -39,516 -11%
ACM
8
Alethea Capital Management
Washington
$402K +$11.7K +2,300 +4%
BCM
9
Bridgeway Capital Management
Texas
$394K – – –
BC
10
Birchview Capital
Vermont
$369K – – –
Geode Capital Management
11
Geode Capital Management
Massachusetts
$306K +$248K +48,972 New
BFA
12
BlackRock Fund Advisors
California
$219K -$1K -198 -0.6%
PPCM
13
Pillar Pacific Capital Management
California
$191K +$155K +30,500 New
Renaissance Technologies
14
Renaissance Technologies
New York
$153K +$56.2K +11,100 +83%
PIM
15
Partner Investment Management
California
$148K +$3.16K +623 +3%
California Public Employees Retirement System
16
California Public Employees Retirement System
California
$147K – – –
Northern Trust
17
Northern Trust
Illinois
$68K +$55.2K +10,887 New
PAM
18
Panagora Asset Management
Massachusetts
$62K +$50K +9,874 New
Morgan Stanley
19
Morgan Stanley
New York
$43K +$26.8K +5,290 +331%
Citigroup
20
Citigroup
New York
$35K +$1.52K +300 +6%
UBS Group
21
UBS Group
Switzerland
$23K +$18.4K +3,631 New
BIM
22
BlackRock Investment Management
Delaware
$16K – – –
MA
23
MUFG Americas
New York
$7K -$2.81K -555 -33%
Manulife (Manufacturers Life Insurance)
24
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$6K – – –
TRCT
25
Tower Research Capital (TRC)
New York
$1K -$51.8K -10,226 -98%
1
2

KURA Hedge Fund Activity: Q3 2016 in Review

28 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2016, worth a combined $60.9M — up 141% from $25.2M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new KURA positions and 3 closed out — a net gain of 3 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was PFM Health Sciences, adding an estimated $1.7M. The largest seller was Boxer Capital, cutting an estimated $509K.

  • 28 institutional investors held Kura Oncology (KURA) as of Q3 2016, up from 25 in Q2 2016.
  • Funds reported $60.9M of Kura Oncology stock for Q3 2016, up 141% quarter-over-quarter.
  • 6 funds opened new Kura Oncology positions in Q3 2016 and 3 closed out, a net change of +3 holders.
  • The largest Kura Oncology buyer in Q3 2016 was PFM Health Sciences, an estimated $1.7M added.
  • The largest Kura Oncology seller in Q3 2016 was Boxer Capital, an estimated $509K sold.

Based on aggregated 13F filings for Q3 2016.